195 related articles for article (PubMed ID: 16039637)
1. Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers.
Michelin K; Wajner A; Bock H; Fachel A; Rosenberg R; Pires RF; Pereira ML; Giugliani R; Coelho JC
Clin Chim Acta; 2005 Dec; 362(1-2):101-9. PubMed ID: 16039637
[TBL] [Abstract][Full Text] [Related]
2. Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects.
Michelin K; Wajner A; Goulart Lda S; Fachel AA; Pereira ML; de Mello AS; Souza FT; Pires RF; Giugliani R; Coelho JC
Clin Chim Acta; 2004 May; 343(1-2):145-53. PubMed ID: 15115687
[TBL] [Abstract][Full Text] [Related]
3. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ
Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease.
Wajner A; Michelin K; Burin MG; Pires RF; Pereira ML; Giugliani R; Coelho JC
Clin Biochem; 2007 Mar; 40(5-6):365-9. PubMed ID: 17291472
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity in type I Gaucher disease.
Devine EA; Beighton P; Petersen EM; Desnick RJ
Prog Clin Biol Res; 1982; 95():495-510. PubMed ID: 6812084
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
Raghavan SS; Topol J; Kolodny EH
Am J Hum Genet; 1980 Mar; 32(2):158-73. PubMed ID: 6770675
[TBL] [Abstract][Full Text] [Related]
7. Infantile Gaucher's disease: glucocerebrosidase deficiency in peripheral blood leukocytes and cultured fibroblasts.
Sengers RC; Lamers KJ; Bakkeren JA; Schretlen ED; Trijbels JM
Neuropadiatrie; 1975 Nov; 6(4):377-82. PubMed ID: 241947
[TBL] [Abstract][Full Text] [Related]
8. Gaucher's disease: a clinical, morphological and biochemical study of a Nigerian family.
Johnson AO; Glew RH; Williams AO
Afr J Med Med Sci; 1980; 9(1-2):27-36. PubMed ID: 6282083
[TBL] [Abstract][Full Text] [Related]
9. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
Choy FY; Bouillon L; Laurin CA
Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases.
Wajner A; Michelin K; Burin MG; Pires RF; Pereira ML; Giugliani R; Coelho JC
Clin Biochem; 2004 Oct; 37(10):893-7. PubMed ID: 15369720
[TBL] [Abstract][Full Text] [Related]
11. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation).
Zimmer KP; le Coutre P; Aerts HM; Harzer K; Fukuda M; O'Brien JS; Naim HY
J Pathol; 1999 Aug; 188(4):407-14. PubMed ID: 10440752
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease.
Beutler E; Beutler L; West C
J Lab Clin Med; 2004 Aug; 144(2):65-8. PubMed ID: 15322500
[TBL] [Abstract][Full Text] [Related]
13. Gaucher disease: a membranous enzymopathy.
Desnick RJ; Grabowski GA; Dinur T; Fabbro D; Goldblatt J; Gatt S
Prog Clin Biol Res; 1982; 97():193-215. PubMed ID: 6818558
[TBL] [Abstract][Full Text] [Related]
14. Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations.
Drugan C; Procopciuc L; Jebeleanu G; Grigorescu-Sido P; Dussau J; Poenaru L; Caillaud C
Eur J Hum Genet; 2002 Sep; 10(9):511-5. PubMed ID: 12173027
[TBL] [Abstract][Full Text] [Related]
15. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity of membrane-bound beta-glucosidase in Gaucher's disease.
Carroll M
J Inherit Metab Dis; 1981; 4(1):11-3. PubMed ID: 6785517
[TBL] [Abstract][Full Text] [Related]
17. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
[TBL] [Abstract][Full Text] [Related]
18. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.
Beutler E; Kuhl W
J Lab Clin Med; 1970 Nov; 76(5):747-55. PubMed ID: 5477334
[No Abstract] [Full Text] [Related]
19. Homozygote and heterozygote identification.
Wenger DA; Roth S
Prog Clin Biol Res; 1982; 95():551-72. PubMed ID: 6812086
[No Abstract] [Full Text] [Related]
20. Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Sawkar AR; Cheng WC; Beutler E; Wong CH; Balch WE; Kelly JW
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15428-33. PubMed ID: 12434014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
